1Y Annualised Return
▼-44.21%
3Y Annualised Return
▼-44.69%
5Y Annualised Return
▲14.65%
ANG Lifesciences India SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹52,48,054 (-19.26%)
Daily SIP of ₹25,000 would have become ₹52,48,054 in 1 year with a gain of ₹-12,51,945 (-19.26%)
ANG Lifesciences India Stock Performance
Today’s Low - High
28.56
29.14
28.56
29.14
52 Week Low - High
21.03
62.75
21.03
62.75
Open
29.14
Prev. Close
29.14
Volume
802.00
Total Traded Value
22905.12
ANG Lifesciences India Fundamental
Market Cap (in crs)
37.29
Face Value
10
Turnover (in lacs)
0.23
Key Metrics
Qtr Change %
54.49% Fall from 52W High
12
Dividend yield 1yr %
0
ANG Lifesciences India Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
ANG Lifesciences India Quarterly Revenue
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
16.82 Cr | 24.73 Cr | 32.88 Cr | 18.41 Cr | 37.84 Cr |
ANG Lifesciences India Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
94.86 Cr | 146.81 Cr | 229.61 Cr | 355.2 Cr |
ANG Lifesciences India Quarterly Net Profit/Loss
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
-2.06 Cr | -5.19 Cr | -2.09 Cr | -3.07 Cr | -3.65 Cr |
ANG Lifesciences India Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
-12.41 Cr | -10.14 Cr | -0.26 Cr | 40.32 Cr |
ANG Lifesciences India Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
28.56
Current Price
5Day EMA
29.20
10Day EMA
29.40
12Day EMA
29.40
20Day EMA
29.30
26Day EMA
29.20
50Day EMA
29.40
100Day EMA
31.80
200Day EMA
37.80
5Day SMA
29.30
10Day SMA
29.70
20Day SMA
29.40
30Day SMA
29.10
50Day SMA
28.50
100Day SMA
30.90
150Day SMA
35.60
200Day SMA
39.20
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 802 Rs | 802 Rs |
Week Rs | 674 Rs | 674 Rs |
Month Rs | 2960 Rs | 2960 Rs |
Resistance & Support
28.75
Pivot
Resistance
First Resistance
28.95
Second Resistance
29.33
Third Resistance
29.53
Support
First Support
28.37
Second support
28.17
Third Support
27.79
Relative Strength Index
44.72
Money Flow Index
65.76
MACD
0.22
MACD Signal
0.38
Average True Range
0.80
Average Directional Index
24.37
Rate of Change (21)
-4.35
Rate of Change (125)
-38.51
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.96 | 35.92 | 9.29 | 27 | 17.90 | 0.56% | 36.16% | -11.66% | -20.46% | 226.55% | 0.00% | 89.80 | 41.51 | 1.62 | |
55.00 | 41.64 | 44.52 | 94.9 | 53.67 | -2.82% | -0.85% | -33.53% | 14.69% | 67.27% | 0.00% | 0.00 | 41.51 | 6.43 | |
30.45 | 30.48 | 26.1 | 44.96 | 30.76 | 0.36% | -5.72% | -18.48% | -22.78% | 27.53% | 0.00% | 101.60 | 41.51 | 0.89 | |
25.43 | 37.25 | 13.11 | 29.12 | 24.22 | 12.22% | 26.14% | 3.88% | 51.82% | 413.74% | 0.00% | 36.86 | 46.01 | 3.71 | |
Vilin Bio Med Ltd. | 28.40 | 28.40 | - | - | - | - | - | - | - | - | - | - | - | - |
Mono Pharmacare Ltd. | 24.45 | 24.45 | - | - | - | - | - | - | - | - | - | - | - | - |
ANG Lifesciences India Company background
Founded in: 2006
Managing director: Rajesh Gupta
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name ANG Lifesciences India Private Limited on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to ANG Lifesciences India Private Limited on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to ANG Lifesciences India Limited on May 18, 2016.The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 200809, the Company started its commercial production. In 201415, it commenced direct sale of medicines covering hospitals , Doctors through stockists. The Company is ISO9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing setup consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These stateofart facilities have integrated process development teams with inhouse engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical equipment. It also has geographical presence across India, Africa, Gulf countries other ROW countries.In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore. The Company acquired Mansa Printers Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.
As of 20 Jun, 2025, ANG Lifesciences India share price is ₹28.6. The stock opened at ₹29.1 and had closed at ₹29.1 the previous day. During today’s trading session, ANG Lifesciences India share price moved between ₹28.56 and ₹29.14, with an average price for the day of ₹28.85. Over the last 52 weeks, the stock has recorded a low of ₹21.03 and a high of ₹62.75. In terms of performance, ANG Lifesciences India share price has declined by 36.9% over the past six months and has declined by 44.21% over the last year.
ANG Lifesciences India FAQs
How to buy ANG Lifesciences India shares?
You can easily buy ANG Lifesciences India shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that ANG Lifesciences India stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account